Squibb announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended ...
Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...
Bristol Myers Squibb (NYSE:BMY) has received a recommendation for approval from the Committee for Medicinal Products for ...
Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...
A couple of weeks later, Hudson became very lethargic and began vomiting. An emergency vet sent him home after inconclusive ...